Research Maatschap Cardiologen Rotterdam Zuid Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2017
NCT03296540
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Research Maatschap Cardiologen Rotterdam Zuid